Ion Exchange is raising $5Mn debt financing from IFC for expanding it's production capacities for resins and chemicals used in water and wastewater treatment, upgrade its resin pharma facility to make it US FDA compliant, upgrade its own ETP facilities located at Patancheru in AP and Ankleshwar in Gujarat and renovation of existing buildings and branch offices located at various locations.

ION Exchange, the ION Exchange group’s flagship company, was incorporated in 1964 as a subsidiary of Permutit Company, UK, with 60% holding. The foreign holding was reduced in stages, and since 1985, the paid-up share capital has been held by resident Indians.

ION Exchange commenced operations at its Ambarnath (Maharashtra) plant in 1965 by manufacturing ion exchange resins and diversifying into chemical treatment of water in 1982.

ION Exchange has three main divisions - engineering, chemical, and consumer products - which it operates through six factories in five states. Each of the businesses is professionally managed by a dedicated team operating the business independently. The engineering division plans and executes orders for installation of large- and medium-sized water and effluent treatment plants.

Ion Exchange on BSE

The chemical division manufactures ion exchange resins and industrial chemicals and sells domestically as well as to the US market. The consumer products division offers a range of water care products for homes and institutions under the Zero-B umbrella brand.

Ion Exchange is also looking to raise PE funding for it's subsidiary -Ion Exchange Services India Ltd to to set up vocational training institute in rural Maharashtra and Tamil Nadu, building the infrastructure and for expansion. The company is also looking at domestic acquisitions to strengthen it's presence across the country.

Previous Article

Inox India Looks For $20Mn Acquisition In Europe

Next Article

PE Backed Augere To Sell 4G Spectrum, Quit India Operations